Registered entities
ARGOS THERAPEUTICS INC
Reg. No. 1105533United States
ARGOS THERAPEUTICS, INC
Reg. No. 562110007United States
Innovation
34 patent families (23 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 4,436 times.
| Year | Filings |
|---|---|
| 2012 | 11 |
| 2013 | 13 |
| 2014 | 11 |
| 2015 | 12 |
| 2016 | 10 |
| 2017 | 8 |
| 2018 | 10 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
Investor mix
31 investors on record; lead investors include Pharmstandard International, Forbion; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 14 | 45% |
| Private equity | 4 | 13% |
| Bank & private debt | 1 | 3% |
| Other / undisclosed | 12 | 39% |